246 related articles for article (PubMed ID: 33558459)
1. The microRNA-195 - BDNF pathway and cognitive deficits in schizophrenia patients with minimal antipsychotic medication exposure.
Pan S; Feng W; Li Y; Huang J; Chen S; Cui Y; Tian B; Tan S; Wang Z; Yao S; Chiappelli J; Kochunov P; Chen S; Yang F; Li CR; Tian L; Tan Y; Elliot Hong L
Transl Psychiatry; 2021 Feb; 11(1):117. PubMed ID: 33558459
[TBL] [Abstract][Full Text] [Related]
2. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
Bora E
Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
[TBL] [Abstract][Full Text] [Related]
3. BDNF serum levels and cognitive improvement in drug-naive first episode patients with schizophrenia: A prospective 12-week longitudinal study.
Wu ZW; Shi H; Chen DC; Chen S; Xiu MH; Zhang XY
Psychoneuroendocrinology; 2020 Dec; 122():104879. PubMed ID: 33049658
[TBL] [Abstract][Full Text] [Related]
4. Brain-derived neurotrophic factor is associated with cognitive impairments in first-episode and chronic schizophrenia.
Yang Y; Liu Y; Wang G; Hei G; Wang X; Li R; Li L; Wu R; Zhao J
Psychiatry Res; 2019 Mar; 273():528-536. PubMed ID: 30710808
[TBL] [Abstract][Full Text] [Related]
5. Sex differences in the association between serum BDNF and cognitive impairment in schizophrenia patients using various antipsychotics.
Dong R; Zhao NO; Wu HE; Yu L; Zhang XY
J Psychiatr Res; 2021 Jun; 138():492-499. PubMed ID: 33971483
[TBL] [Abstract][Full Text] [Related]
6. Superoxide Dismutase, BDNF, and Cognitive Improvement in Drug-Naive First-Episode Patients With Schizophrenia: A 12-Week Longitudinal Study.
Wu Z; Liu Q; Zhang Y; Guan X; Xiu M; Zhang X
Int J Neuropsychopharmacol; 2022 Feb; 25(2):128-135. PubMed ID: 34622272
[TBL] [Abstract][Full Text] [Related]
7. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
8. [Effects of oxidative stress on cognitive impairment in first episode schizophrenia].
Wang YP; Zhang PF; Yuan XX; Liu YF; Li HH; Tao Q; Li X; Pang LJ; Song XQ
Zhonghua Yi Xue Za Zhi; 2019 Jan; 99(1):9-13. PubMed ID: 30641657
[No Abstract] [Full Text] [Related]
9. The influence of impaired processing speed on cognition in first-episode antipsychotic-naïve schizophrenic patients.
Andersen R; Fagerlund B; Rasmussen H; Ebdrup BH; Aggernaes B; Gade A; Oranje B; Glenthoj B
Eur Psychiatry; 2013 Aug; 28(6):332-9. PubMed ID: 22999439
[TBL] [Abstract][Full Text] [Related]
10. Cognitive impairments and low BDNF serum levels in first-episode drug-naive patients with schizophrenia.
Man L; Lv X; Du XD; Yin G; Zhu X; Zhang Y; Soares JC; Yang XN; Chen X; Zhang XY
Psychiatry Res; 2018 May; 263():1-6. PubMed ID: 29482040
[TBL] [Abstract][Full Text] [Related]
11. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
12. Effects of microRNA-181b-5p on cognitive deficits in first-episode patients with schizophrenia: Mediated by BCL-2.
Gou M; Pan S; Tong J; Zhou Y; Han J; Xie T; Yu T; Feng W; Li Y; Chen S; Cui Y; Tian B; Tan MDS; Wang Z; Luo X; Li CR; Zhang P; Huang J; Hong LE; Tan Y; Tian L
J Psychiatr Res; 2021 Apr; 136():358-365. PubMed ID: 33636692
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of the MATRICS Consensus Cognitive Battery in a 29-site antipsychotic schizophrenia clinical trial.
Keefe RS; Fox KH; Harvey PD; Cucchiaro J; Siu C; Loebel A
Schizophr Res; 2011 Feb; 125(2-3):161-8. PubMed ID: 21075600
[TBL] [Abstract][Full Text] [Related]
14. Altered BDNF is correlated to cognition impairment in schizophrenia patients with tardive dyskinesia.
Wu JQ; Chen DC; Tan YL; Tan SP; Hui L; Lv MH; Soares JC; Zhang XY
Psychopharmacology (Berl); 2015 Jan; 232(1):223-32. PubMed ID: 24994553
[TBL] [Abstract][Full Text] [Related]
15. Cognitive performance during the first year of treatment in first-episode schizophrenia: a case-control study.
Olivier MR; Killian S; Chiliza B; Asmal L; Schoeman R; Oosthuizen PP; Kidd M; Emsley R
Psychol Med; 2015 Oct; 45(13):2873-83. PubMed ID: 25998030
[TBL] [Abstract][Full Text] [Related]
16. Increased serum brain-derived neurotrophic factor levels following electroconvulsive therapy or antipsychotic treatment in patients with schizophrenia.
Li J; Ye F; Xiao W; Tang X; Sha W; Zhang X; Wang J
Eur Psychiatry; 2016 Aug; 36():23-8. PubMed ID: 27311104
[TBL] [Abstract][Full Text] [Related]
17. Serum brain-derived neurotrophic factors in Taiwanese patients with drug-naïve first-episode schizophrenia: Effects of antipsychotics.
Chiou YJ; Huang TL
World J Biol Psychiatry; 2017 Aug; 18(5):382-391. PubMed ID: 27643618
[TBL] [Abstract][Full Text] [Related]
18. [Cognition, schizophrenia and the effect of antipsychotics].
Stip E
Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928
[TBL] [Abstract][Full Text] [Related]
19. Correlation of BDNF, VEGF, TNF-α, and S100B with cognitive impairments in chronic, medicated schizophrenia patients.
Chukaew P; Bunmak N; Auampradit N; Siripaiboonkij A; Saengsawang W; Ratta-Apha W
Neuropsychopharmacol Rep; 2022 Sep; 42(3):281-287. PubMed ID: 35733332
[TBL] [Abstract][Full Text] [Related]
20. Metabolic adverse effects of olanzapine on cognitive dysfunction: A possible relationship between BDNF and TNF-alpha.
Zhang C; Fang X; Yao P; Mao Y; Cai J; Zhang Y; Chen M; Fan W; Tang W; Song L
Psychoneuroendocrinology; 2017 Jul; 81():138-143. PubMed ID: 28477447
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
